CN104474148A - 用于治疗真菌性皮肤病的中药组合物及其制备方法 - Google Patents
用于治疗真菌性皮肤病的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN104474148A CN104474148A CN201510022385.6A CN201510022385A CN104474148A CN 104474148 A CN104474148 A CN 104474148A CN 201510022385 A CN201510022385 A CN 201510022385A CN 104474148 A CN104474148 A CN 104474148A
- Authority
- CN
- China
- Prior art keywords
- herba
- parts
- radix
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 92
- 239000000203 mixture Substances 0.000 title claims abstract description 38
- 208000007163 Dermatomycoses Diseases 0.000 title claims abstract description 26
- 201000003929 dermatomycosis Diseases 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 229940079593 drug Drugs 0.000 claims abstract description 37
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 22
- 241001148752 Diplazium Species 0.000 claims abstract description 20
- 241000628997 Flos Species 0.000 claims description 21
- 240000005819 Magnolia denudata Species 0.000 claims description 21
- 235000016094 Magnolia denudata Nutrition 0.000 claims description 21
- 241000717739 Boswellia sacra Species 0.000 claims description 19
- 239000004863 Frankincense Substances 0.000 claims description 19
- 241001057584 Myrrha Species 0.000 claims description 19
- 241001053158 Oxytropis Species 0.000 claims description 19
- 210000000582 semen Anatomy 0.000 claims description 19
- 241000167881 Hirundo Species 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 16
- 238000010438 heat treatment Methods 0.000 claims description 12
- 239000002674 ointment Substances 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 238000009835 boiling Methods 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 238000000108 ultra-filtration Methods 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 7
- 238000004321 preservation Methods 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000002552 dosage form Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 238000012536 packaging technology Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 238000009991 scouring Methods 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 24
- 210000004369 blood Anatomy 0.000 abstract description 24
- 230000000694 effects Effects 0.000 abstract description 24
- 230000006870 function Effects 0.000 abstract description 21
- 208000002193 Pain Diseases 0.000 abstract description 13
- 230000036407 pain Effects 0.000 abstract description 13
- 201000010099 disease Diseases 0.000 abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 12
- 208000003251 Pruritus Diseases 0.000 abstract description 10
- 206010061218 Inflammation Diseases 0.000 abstract description 9
- 241000233866 Fungi Species 0.000 abstract description 8
- 231100000331 toxic Toxicity 0.000 abstract description 8
- 230000002588 toxic effect Effects 0.000 abstract description 8
- 230000007803 itching Effects 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 239000002671 adjuvant Substances 0.000 abstract description 2
- 210000004877 mucosa Anatomy 0.000 abstract description 2
- 230000003260 anti-sepsis Effects 0.000 abstract 3
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241000816554 Achnatherum inebrians Species 0.000 abstract 1
- 241000759271 Alangium Species 0.000 abstract 1
- 241000123850 Aster ageratoides Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 244000085918 Eucalyptus exserta Species 0.000 abstract 1
- 235000002633 Eucalyptus exserta Nutrition 0.000 abstract 1
- 241000006349 Hemiphragma heterophyllum Species 0.000 abstract 1
- 241000039538 Illicium ternstroemioides Species 0.000 abstract 1
- 241000218313 Liriodendron chinense Species 0.000 abstract 1
- 241000218378 Magnolia Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 241000736199 Paeonia Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241001146210 Senecio scandens Species 0.000 abstract 1
- 241001119316 Thalictrum petaloideum Species 0.000 abstract 1
- 241001302407 Viola diamantiaca Species 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 230000008030 elimination Effects 0.000 abstract 1
- 238000003379 elimination reaction Methods 0.000 abstract 1
- 239000013521 mastic Substances 0.000 abstract 1
- 239000002689 soil Substances 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 22
- 239000000796 flavoring agent Substances 0.000 description 18
- 235000019634 flavors Nutrition 0.000 description 18
- 241000700199 Cavia porcellus Species 0.000 description 10
- 208000002474 Tinea Diseases 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 231100000614 poison Toxicity 0.000 description 9
- 230000008961 swelling Effects 0.000 description 9
- 230000000844 anti-bacterial effect Effects 0.000 description 8
- 201000004624 Dermatitis Diseases 0.000 description 7
- 241000130764 Tinea Species 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 231100000252 nontoxic Toxicity 0.000 description 7
- 230000003000 nontoxic effect Effects 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 7
- 239000003440 toxic substance Substances 0.000 description 7
- 241000411851 herbal medicine Species 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 5
- 206010017553 Furuncle Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 230000004069 differentiation Effects 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 244000045947 parasite Species 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 230000008736 traumatic injury Effects 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 206010063409 Acarodermatitis Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 241000447727 Scabies Species 0.000 description 4
- 206010040943 Skin Ulcer Diseases 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000002951 depilatory effect Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 206010022000 influenza Diseases 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 208000005687 scabies Diseases 0.000 description 4
- 231100000019 skin ulcer Toxicity 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010040844 Skin exfoliation Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 239000003908 antipruritic agent Substances 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000035617 depilation Effects 0.000 description 3
- RZUHGAKUNBFQJS-UHFFFAOYSA-N didehydroglaucine Natural products COC1=C(OC)C2=C(C=C(C(OC)=C3)OC)C3=CC(N(C)CC3)=C2C3=C1 RZUHGAKUNBFQJS-UHFFFAOYSA-N 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 206010044008 tonsillitis Diseases 0.000 description 3
- 208000004371 toothache Diseases 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- MFIHSKBTNZNJIK-RZTYQLBFSA-N (3s,3ar,6s,6ar)-3-(3,4-dimethoxyphenyl)-6-(3,4,5-trimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan Chemical compound C1=C(OC)C(OC)=CC=C1[C@@H]1[C@@H](CO[C@@H]2C=3C=C(OC)C(OC)=C(OC)C=3)[C@@H]2CO1 MFIHSKBTNZNJIK-RZTYQLBFSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 206010012504 Dermatophytosis Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 206010019345 Heat stroke Diseases 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241001460074 Microsporum distortum Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 240000005001 Paeonia suffruticosa Species 0.000 description 2
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 206010043866 Tinea capitis Diseases 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 2
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 208000002352 blister Diseases 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 230000035618 desquamation Effects 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 206010016766 flatulence Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 230000003118 histopathologic effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 206010034754 petechiae Diseases 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 201000009862 superficial mycosis Diseases 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 201000004647 tinea pedis Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- YLRXAIKMLINXQY-ZDUSSCGKSA-O (S)-magnoflorine Chemical compound C1=C(OC)C(O)=C2C3=C(O)C(OC)=CC=C3C[C@@H]3[N+](C)(C)CCC1=C23 YLRXAIKMLINXQY-ZDUSSCGKSA-O 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 244000296912 Ageratum conyzoides Species 0.000 description 1
- 235000004405 Ageratum conyzoides Nutrition 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000016535 Capraria biflora Nutrition 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000006348 Hemiphragma Species 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 208000029951 Laryngeal disease Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- KYEAXNAYHSCLMT-CVVGWEDFSA-N Magnoflorine Natural products C[C@H]1OC=C2[C@@H]3[C@@H]1CN4CCc5c([nH]c6ccccc56)[C@@H]4[C@@H]3OC2=O KYEAXNAYHSCLMT-CVVGWEDFSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 241000893980 Microsporum canis Species 0.000 description 1
- 241000187480 Mycobacterium smegmatis Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 241000893976 Nannizzia gypsea Species 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 208000024818 Nipple disease Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000007712 Tinea Versicolor Diseases 0.000 description 1
- 201000010618 Tinea cruris Diseases 0.000 description 1
- 206010056131 Tinea versicolour Diseases 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 208000026816 acute arthritis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 208000008025 hordeolum Diseases 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- MFIHSKBTNZNJIK-UHFFFAOYSA-N medioresinol dimethyl ether Natural products C1=C(OC)C(OC)=CC=C1C1C(COC2C=3C=C(OC)C(OC)=C(OC)C=3)C2CO1 MFIHSKBTNZNJIK-UHFFFAOYSA-N 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 229910000480 nickel oxide Inorganic materials 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940100691 oral capsule Drugs 0.000 description 1
- GNRSAWUEBMWBQH-UHFFFAOYSA-N oxonickel Chemical compound [Ni]=O GNRSAWUEBMWBQH-UHFFFAOYSA-N 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 208000009189 tinea favosa Diseases 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229940055035 trichophyton verrucosum Drugs 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种用于治疗真菌性皮肤病的中药组合物及其制备方法,本发明药物符合中药配伍的原理,首先从根本上入手,以山白菊、鹰不扑、牛至、凹朴皮、牡丹花和冰片为君药杀死和消除皮肤表皮下面的真菌,在处方中起到了抗菌消炎,止痛止痒,治疗多种皮肤粘膜疾病的关键作用,以寸节七、八角枫叶、八角香、醉马草、燕窠土为臣药,止痛止痒、活血散瘀、抗菌消炎;以瓣蕊唐松草、鞭打绣球、窿缘桉叶、篱栏子、篦梳剑为佐药,起协调作用,加强君药和臣药的治疗功能,制约其他药物的毒副作用;以没药、千里光、玉兰花、苦参、乳香抗菌消炎、散肿止痛、祛湿止痒之功,指引导诸药直达病所。
Description
技术领域
本发明涉及医药学技术领域,具体地说是一种用于治疗真菌性皮肤病的中药组合物及其制备方法。
背景技术
真菌性皮肤病,亦称皮肤真菌病,是指由病原真菌所引起的人类皮肤以及黏膜、毛发和甲等皮肤附属器的一大类感染性疾病。是皮肤癣菌侵犯表皮,所引起的浅部真菌感染性疾病。临床上多呈水疱鳞屑型表现,损害多限于一侧,初发生小水疱,数目多少不一,疱液干涸后脱屑,范围日渐扩大,久之脱屑处皮肤粗糙增厚,皮纹宽深,失去正常的光泽,柔韧性,触之有粗沙感。
皮肤癣菌是真菌性皮肤病的主要致病菌,有红色毛癣菌、石膏样毛癣菌、絮状表皮癣菌、疣状毛癣菌、大小孢子菌等。此类疾病的共同特点是:发病率高、具有传染性、易复发或再感染。特别不合理、不规范的治疗会造成反复发作、反复治疗,极大的影响患者的生活质量。真菌喜欢温暖潮湿,浅部真菌最适宜的温度是22℃~28℃。当人体皮肤上有适合真菌生长繁殖的条件时,就容易发生癣病。如有些人容易出汗,皮肤容易潮湿,如不及时擦净和保持干燥,容易感染真菌而发生花斑癣等癣病;所穿裤子过紧过厚不透气、长时间坐办公室,容易患股癣等癣病;经常穿胶鞋、皮鞋、运动鞋,如透气性差,脚部的湿度和温度增高,若再加上皮肤不干净,就极易发生足癣等癣病。而且,身体上如果有了一种癣病,还会通过自身传播而使其他部位也发生癣病。
然而目前治疗真菌性皮肤病的药物琳琅满目,治疗效果也都是一般,见效慢,有些化学成分含有激素类药物,治愈后容易复发,因此市场还需要研究一种治疗效果显著,见效快,无副作用,无刺激的,不复发的一种用于治疗真菌性皮肤病的中药组合物及其制备方法。
发明内容
本发明的目的在于克服现有技术的不足提供一种用于治疗真菌性皮肤病的中药组合物及其制备方法,本发明药物符合中药配伍的原理,首先从根本上入手,以山白菊、鹰不扑、牛至、凹朴皮、牡丹花和冰片为君药杀死和消除皮肤表皮下面的真菌,在处方中起到了抗菌消炎,止痛止痒,治疗多种皮肤粘膜疾病的关键作用,以寸节七、八角枫叶、八角香、醉马草、燕窠土为臣药伙同君药中的山白菊、鹰不扑、牛至、凹朴皮、牡丹花和冰片,止痛止痒、活血散瘀、抗菌消炎;以瓣蕊唐松草、鞭打绣球、窿缘桉叶、篱栏子、篦梳剑为佐药,起协调作用,加强君药和臣药的治疗功能,制约其他药物的毒副作用;以没药、千里光、玉兰花、苦参、乳香抗菌消炎、散肿止痛、祛湿止痒之功,指引导诸药直达病所。这些原料组合使得各药物功效产生协同作用,标本兼顾,用药平和,从而能够有效的治疗各种病原微生物及其它原因引起的真菌性皮肤病,本发明能达到理想的治疗效果,且安全,毒副作用小,制备简单,能直达病灶,治愈时间短,治愈后不易复发。。
用于治疗真菌性皮肤病的中药组合物,其特征在于:是由以下重量份的原料制成:
山白菊40-50份、鹰不扑40-50份、牛至40-50份、凹朴皮40-50份、牡丹花40-50份、冰片40-50份、寸节七30-40份、八角枫叶30-40份、八角香30-40份、醉马草30-40份、燕窠土30-40份、瓣蕊唐松草20-30份、鞭打绣球20-30份、窿缘桉叶20-30份、篱栏子20-30份、篦梳剑20-30份、没药10-20份、千里光10-20份、玉兰花10-20份、苦参10-20份、乳香10-20份。
用于治疗真菌性皮肤病的中药组合物,其特征在于:是由以下重量份的原料制成:
山白菊42-48份、鹰不扑42-48份、牛至42-48份、凹朴皮42-48份、牡丹花42-48份、冰片42-48份、寸节七32-38份、八角枫叶32-38份、八角香32-38份、醉马草32-38份、燕窠土32-38份、瓣蕊唐松草22-28份、鞭打绣球22-28份、窿缘桉叶22-28份、篱栏子22-28份、篦梳剑22-28份、没药12-18份、千里光12-18份、玉兰花12-18份、苦参12-18份、乳香12-18份。
用于治疗真菌性皮肤病的中药组合物,其特征在于:是由以下重量份的原料制成:
山白菊45份、鹰不扑45份、牛至45份、凹朴皮45份、牡丹花45份、冰片45份、寸节七35份、八角枫叶35份、八角香35份、醉马草35份、燕窠土35份、瓣蕊唐松草25份、鞭打绣球25份、窿缘桉叶25份、篱栏子25份、篦梳剑25份、没药15份、千里光15份、玉兰花15份、苦参15份、乳香15份。
其中,所述中药组合物的剂型为膏剂和液体擦洗剂。
本发明还提供了上述中药组合物的制备方法,当所述中药组合物的剂型为中药膏剂时,具体为:
按配方比例取各组分药物加入5-10倍量的60-90%乙醇浸泡1-2小时,热提取2次,每次1-2小时,去上清液,合并提取液, 80-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时 1.36的浸膏,加热浓缩,30分钟~45分钟,提取活性成份,将浓缩液静置成浸膏状,药糊继续加热浓缩至浸膏状,静置后搅拌均匀,再经过冷藏、压平、杀菌封装工艺即成本发明的中药膏剂。
本发明还提供了上述中药组合物的制备方法,当所述中药组合物的剂型为中药擦洗剂时,具体为:
按配方比例将各组分药物分别粉碎,按比例混合,获得混合物,加水至淹没混合物药面3~5cm,浸泡1~2小时,加热煎煮,煮沸后用文火,第一次沸后煎煮2~4小时,滤出药液,滤渣中再次加水至淹没混合物药面3~5cm,加热煮沸,煮沸后用文火,第二次沸后煎煮1~2小时,滤过,合并两次过滤的药液,加入占药液质量0.5%活性炭,保持PH值7.0,加热微沸15分钟,冷却,滤过,袋装,于115℃灭菌30分钟,冷藏48小时,即得本发明的中药擦洗剂。
本发明还提供了一种用于治疗真菌性皮肤病的中药膏剂,所述中药膏剂的原料药包括山白菊、鹰不扑、牛至、凹朴皮、牡丹花和冰片、寸节七、八角枫叶、八角香、醉马草、燕窠土、瓣蕊唐松草、鞭打绣球、窿缘桉叶、篱栏子、篦梳剑、没药、千里光、玉兰花、苦参、乳香。
本发明还提供了一种用于治疗真菌性皮肤病的中药擦洗剂,所述中药擦洗剂的原料药包括山白菊、鹰不扑、牛至、凹朴皮、牡丹花和冰片、寸节七、八角枫叶、八角香、醉马草、燕窠土、瓣蕊唐松草、鞭打绣球、窿缘桉叶、篱栏子、篦梳剑、没药、千里光、玉兰花、苦参、乳香。
本发明的有益效果:
本发明配方简单、制作工艺简便,毒副作用小且给药方便,药剂易于制造,成本低廉,且气味不会引起患儿抗拒。本发明使皮肤真菌部位病灶受到良性刺激,抗菌消炎、止痛止痒,促进血液畅通,达到扶正祛邪作用,临床疗效甚佳。本发明采用不同药性的中药材,进行了科学配伍,能达到理想的治疗效果,且安全,毒副作用小,制备简单,能直达病灶,治愈时间短,治愈后不易复发。
本发明所选用药物的药性及药理分别为:
山白菊:
【性味】 味苦辛性凉
【功能主治】清热解毒祛痰镇咳凉血止血主治感冒发热扁桃体炎支气管炎肝炎痢疾热淋血热吐衄血痈肿疔毒蛇虫咬伤
抗菌与抗病毒作用煎剂对金黄色葡萄球菌卡他球菌及奈瑟氏菌有一定的抑制作用体外 对流感病毒亚洲甲型江西地方株昌医58-3株在体外有抑制作用但在体内鸡胚则无小鼠酚红法证明所含槲皮素0.4g/kg 山柰酚0.3g/kg有较好的祛痰作用
鹰不扑:
为五加科植物虎刺楤木的根、根皮或枝叶。生于山坡疏林下及溪进、草丛阳光充足的地方。根全年可采,枝叶夏、秋季采收.
【性味】味辛,性温,无毒。
【功用】散瘀消肿,祛风利湿。
治跌打损伤,风湿痹痛,胃痛,腹泻,痢疾,白带,痈疽,疔肿。
①《广西中草药》:散瘀消肿,祛风湿。
治跌打,风湿疼痛。
②《广西实用中草药新选》:散瘀消肿,抗菌止痛。
治跌打损伤,痈,疖,肝炎,肾炎,前列腺炎,急性关节炎,胃痛,腹泻,痢疾,白带。
牛至:
【性味】味辛、性凉、无毒,全草可入药;
【功用】具有清热解表、理气化湿倒尿消肿之功效。
临床用于预防流感治疗黄疽、中暑、发热、呕吐、急性胃肠炎、腹痛等症,其散寒解表功用胜于薄荷。美国农业部的“植物化学和植物物种学”背景资料表明,牛至含有30多种抗菌化合物,是一种潜在的天然抗生素和药物生长促进剂。
全草入药,可预防流感,治中暑、感冒、头痛身重、腹痛、呕吐、胸膈胀满、气阻食滞、小儿食积腹胀、腹泻、月经过多、崩漏带下、皮肤搔痒及水肿等症,其散寒发表功用,尤胜于薄荷。
凹朴皮:
【性味】辛;性温
【功能主治】祛风除湿;散寒止咳。主风湿痹痛;风寒咳嗽
药理作用
抗菌作用 心材乙醇提取物具有抗菌作用,对金黄色葡萄球菌、包皮垢分枝杆菌、白色念珠菌及黑曲霉等有效,进一步证明抗菌有效成分为去氢海罂粟碱(dehydroglaucine)。
牡丹花:
牡丹不仅有观赏价值,而且还具有很高的药用价值。将牡丹的根加工制成“丹皮”,是名贵的中草药。其性微寒,味辛,无毒,入心、肝、肾三经,有散瘀血、清血、和血、止痛、通经之作用,还有降低血压、抗菌消炎之功效,久服可益身延寿。养血和肝,散郁祛瘀、适用于面部黄褐斑,皮肤衰老,常饮气血活肺,容颜红润,改善月经失调,痛经,止虚汗,盗汗。
冰片:
【性味归经】味辛、苦,微寒;归心、脾,肺烃。
【功用】开窍醒神,清热止痛。
古籍摘要
1.《新修本草》:“主心腹邪气,风湿积聚,耳聋,明目,去目赤肤翳。”
2.《本草纲目》:“疗喉痹、脑痛、鼻瘜、齿痛、伤寒舌出、小儿痘陷。通诸窍,散郁火。”
3.《医林纂要》:“冰片主散郁火,能透骨热,治惊痫、痰迷、喉痹,舌胀、牙痛、耳聋、鼻息、目赤浮翳、痘毒内陷、杀虫、痔疮、催生,性走而不守,亦能生肌止痛[1] 。然散而易竭,是终归阴寒也。”
寸节七:
清热解毒止血用于疮疖肿毒麦粒肿毒蛇咬伤外伤出血肺结核
八角枫叶:
【性味归经】辛苦平归肝肾经
【功能主治】解毒消肿化瘀止痛跌打瘀肿骨折疮肿乳痈乳头皲裂漆疮疥癣鹤膝风外伤出血
八角香:
【性味】性温味辛
【功用】具有散寒解毒杀虫之功效常用于风湿浮肿无名肿毒癞癣
醉马草:
【功能主治】麻醉镇静止痛治关节痛牙痛神经衰弱皮肤瘙痒
燕窠土:
【性味】①《本草拾遗》:无毒。
②《四川中药志》:性寒,味咸,无毒。
①《本草拾遗》:主风瘙瘾疹。
末,以水和敷之。
②《纲目》:治口吻、白秃诸疮。
瓣蕊唐松草:
【性味】味苦;性寒
【归经】归肝;胃;大肠经
【功能主治】清热;燥湿;解毒。主治湿热泻痢;黄疸;肺热咳嗽;目赤肿痛;痈肿疮疖;渗出性皮炎,外用止血《藏本草》,能清热祛风,去皮里膜外及筋络之郁热。治小儿热症伤风及豆疹难透。
鞭打绣球:
【科目来源】为玄参科植物羊膜草的全草或根。
【性味】味微甘;淡;性温。①《植物名实图考》: “性温,味微甘。”②《贵州草药》: “性平,味微甘。”③《西藏常用中草药》: “性温,味淡。”
【归经】归心;肝经 。
【功能与主治】活血调经,舒筋活络,祛风除湿。用于经闭,月经不调,肺结核,扁桃体炎,跌打损伤,风湿腰痛;益气止痛,去瘀止血,治咳嗽吐血,神经衰弱,经闭腹痛;外用治湿疹,疮疡,口腔炎,瘰疬,疮肿湿毒,破伤风。
窿缘桉叶:
【性味】味辛;苦;性温
【功能主治】祛风止痒;燥湿杀虫。主风湿疹痒;脚气湿痒;风湿痹痛。
篱栏子:
【性味】甘;淡;凉
【归经】肺;脾经
【功用主治】①《岭南采药录》:清凉散热,治喉痛,去痰火,治双单蛾喉症。
研末吹喉。
②《广西药植名录》:全株,外用治疮疥。
篦梳剑:
【性味】苦;涩;微寒;无毒
【归经】肺;肾经
【功能主治】止血通淋;清热解毒。主咳血;淋证;尿血;小儿疳积;脚癣。
没药:
【性味】苦,辛,平。
【功用】抗菌、抗微生物、抗炎、收敛、具香胶特质、除臭、祛肠胃胀气、消毒、利尿、通经、化痰、杀霉菌、激励、利胃、催汗、补身、利子宫、治创伤,对成熟\干裂\脱粗糙皮肤有助益。
千里光:
【性味归经】苦,甘,寒,辛,凉。无毒。
【功能主治】清热解毒、杀虫、明目。现代药理研究:1、抗菌作用,对志贺氏痢疾杆菌、金黄色葡萄球菌、腊样炭疽杆菌有较强的抗菌作用。2、抗螺旋体作用。3、抑制阴道滴虫作用。《中药大辞典》报道用于治疗:各种炎症性疾病疥癞疮毒、湿疹、阴道滴虫、各型阴道炎、宫颈炎、痈疽、痔疮等。
玉兰花:
【性味】性味辛、温。
【功能主治】具有祛风散寒通窍、宣肺通鼻的功效。可用于头痛、血瘀型痛经、鼻塞、急慢性鼻窦炎、过敏性鼻炎等症。现代药理学研究表明,玉兰花对常见皮肤真菌有抑制作用。其花瓣可供食用,肉质较厚,具特有清香,清代《花镜》谓:“其(花)瓣择洗清洁,拖面麻油煎食极佳,或蜜浸亦可。” 玉兰花含有挥发油,其中主要为柠檬醛、丁香油酸等,还含有木兰花碱、生物碱、望春花素、癸酸、芦丁、油酸、维生素A等成分,具有一定的药用价值。
苦参:
【性味归经】苦,寒;归心、肝、胃、大肠、膀胱经。
【功效】清热燥湿,杀虫,利尿。用于热痢,便血,黄疸尿闭,赤白带下,阴肿阴痒,湿疹,湿疮,皮肤瘙痒,疥癣麻风;外治滴虫性阴道炎。
乳香:调气,活血,止痛,追毒。抗菌、收敛、祛肠胃胀气、促进伤口结疤、增进细胞活性、利消化、利尿、镇静、补身、利子宫、治创伤。
具体实施方式:
实施例1,配方:
山白菊40g、鹰不扑40g、牛至40g、凹朴皮40g、牡丹花40g、冰片40g、寸节七30g、八角枫叶30g、八角香30g、醉马草30g、燕窠土30g、瓣蕊唐松草20g、鞭打绣球20g、窿缘桉叶20g、篱栏子20g、篦梳剑20g、没药10g、千里光10g、玉兰花10g、苦参10g、乳香10g;
制备方法具体为:
按配方比例将药物山白菊40g、鹰不扑40g、牛至40g、凹朴皮40g、牡丹花40g、冰片40g、寸节七30g、八角枫叶30g、八角香30g、醉马草30g、燕窠土30g、瓣蕊唐松草20g、鞭打绣球20g、窿缘桉叶20g、篱栏子20g、篦梳剑20g、没药10g、千里光10g、玉兰花10g、苦参10g、乳香10g分别粉碎,按比例混合,获得混合物,加水至淹没混合物药面3~5cm,浸泡1~2小时,加热煎煮,煮沸后用文火,第一次沸后煎煮2~4小时,滤出药液,滤渣中再次加水至淹没混合物药面3~5cm,加热煮沸,煮沸后用文火,第二次沸后煎煮1~2小时,滤过,合并两次过滤的药液,加入占药液质量0.5%活性炭,保持PH值7.0,加热微沸15分钟,冷却,滤过,袋装,于115℃灭菌30分钟,冷藏48小时,即得本发明的中药擦洗剂。
实施例2,配方:
山白菊42g、鹰不扑42g、牛至42g、凹朴皮42g、牡丹花42g、冰片42g、寸节七32g、八角枫叶32g、八角香32g、醉马草32g、燕窠土32g、瓣蕊唐松草22g、鞭打绣球22g、窿缘桉叶22g、篱栏子22g、篦梳剑22g、没药12g、千里光12g、玉兰花12g、苦参12g、乳香12g;
制备方法具体为:
按配方比例将药物山白菊42g、鹰不扑42g、牛至42g、凹朴皮42g、牡丹花42g、冰片42g、寸节七32g、八角枫叶32g、八角香32g、醉马草32g、燕窠土32g、瓣蕊唐松草22g、鞭打绣球22g、窿缘桉叶22g、篱栏子22g、篦梳剑22g、没药12g、千里光12g、玉兰花12g、苦参12g、乳香12g加入5-10倍量的60-90%乙醇浸泡1-2小时,热提取2次,每次1-2小时,去上清液,合并提取液, 80-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时 1.36的浸膏,加热浓缩,30分钟~45分钟,提取活性成份,将浓缩液静置成浸膏状,药糊继续加热浓缩至浸膏状,静置后搅拌均匀,再经过冷藏、压平、杀菌封装工艺即成本发明的中药膏剂。
实施例3,配方:
山白菊45g、鹰不扑45g、牛至45g、凹朴皮45g、牡丹花45g、冰片45g、寸节七35g、八角枫叶35g、八角香35g、醉马草35g、燕窠土35g、瓣蕊唐松草25g、鞭打绣球25g、窿缘桉叶25g、篱栏子25g、篦梳剑25g、没药15g、千里光15g、玉兰花15g、苦参15g、乳香15g。
制备方法与实施例1相同。
实施例4,配方:
山白菊48g、鹰不扑48g、牛至48g、凹朴皮48g、牡丹花48g、冰片48g、寸节七38g、八角枫叶38g、八角香38g、醉马草38g、燕窠土38g、瓣蕊唐松草28g、鞭打绣球28g、窿缘桉叶28g、篱栏子28g、篦梳剑28g、没药18g、千里光18g、玉兰花18g、苦参18g、乳香18g;
制备方法具体为:
按配方比例取药物山白菊48g、鹰不扑48g、牛至48g、凹朴皮48g、牡丹花48g、冰片48g、寸节七38g、八角枫叶38g、八角香38g、醉马草38g、燕窠土38g、瓣蕊唐松草28g、鞭打绣球28g、窿缘桉叶28g、篱栏子28g、篦梳剑28g、没药18g、千里光18g、玉兰花18g、苦参18g、乳香18g加入5-10倍量的60-90%乙醇浸泡1-2小时,热提取2次,每次1-2小时,去上清液,合并提取液, 80-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时 1.36的浸膏,加热浓缩,30分钟~45分钟,提取活性成份,将浓缩液静置成浸膏状,药糊继续加热浓缩至浸膏状,静置后搅拌均匀,再经过冷藏、压平、杀菌封装工艺即成本发明的中药膏剂。
实施例5,配方:
山白菊50g、鹰不扑50g、牛至50g、凹朴皮50g、牡丹花50g、冰片50g、寸节七40g、八角枫叶40g、八角香40g、醉马草40g、燕窠土40g、瓣蕊唐松草30g、鞭打绣球30g、窿缘桉叶30g、篱栏子30g、篦梳剑30g、没药20g、千里光20g、玉兰花20g、苦参20g、乳香20g;
制备方法与实施例1相同。
急性毒性实验资料
1、实验方法
将豚鼠背部脊柱两侧将脱毛剂均匀涂上,使去毛范围约20平方厘米。洗净脱毛剂归笼观察24小时,每组豚鼠分别涂本发明中药制剂膏剂0.2、0.4和0.8ml,本发明中药制剂擦洗剂0.2、0.4和0.8ml,分别含生药92、184和368mg,另一组涂溶媒0.8ml每日二次,连续一周,实验结束后,将豚鼠处死,心,肝,肾及脱毛皮肤做病理检验。
、结果
上述三组用药豚鼠躯干脱毛区,未见局部皮肤有水肿、充血、红斑、出血点及溃疡。用药组豚鼠毛发色泽、摄食、四肢活动等对照组无明显差异,病理组织学检查,给药组心、肝、肾及脱毛皮与对照字比较也无明显差异。
结果提示,本发明中药外用制剂无局部刺激作用,也未见全身毒性表现。表明本发明中药外用制剂使用安全。
长期毒性实验资料
1、实验方法
将豚鼠随机份成4组,每组15只。在豚鼠背部脊柱两侧将脱毛剂均匀涂上,使其脱毛范围约20平方厘米。洗净脱毛剂,观察24小时后每组豚鼠分别涂本发明中药制剂膏剂0.2、0.4和0.8ml,本发明中药制剂擦洗剂0.2、0.4和0.8ml,分别含生药92、184和368mg,另一组涂溶媒0.8ml每日二次,连续30天,观察豚鼠的一般情况,实验结束后处死动物进行血液学、血液生化及病理学检查。
、结果
上述三组用药豚鼠躯干去毛区,未见局部皮肤有水肿、充血、红斑、出血点及溃疡。用药组与对照组动物毛发色泽、摄食、四肢活动等对照组无明显差异,血液生化检查,用药组与对照组均在正常范围。病理组织学检查,实验各组心、肝、肾及局部皮肤均未见明显病变。
提示,本发明中药制剂长期用药对局部皮肤及全身重要脏器均未见明显的毒性作用。试验结果表明:本发明中药制剂实验安全。
累计毒性实验:
本发明中药制剂对小鼠按7.69、19.18和43.21g生药/kg连续用药15周(1.0ml/100g体重,每天2次)及停药3周后,结果表明:本发明中药制剂对大鼠的毛发、行为、大小便、体重、脏器重量、血象、肝肾功能、血糖、血脂等指标均无明显影响,脏器肉眼没有发现异样变化和组织学检查结果表明,用药15周及停药3周后,大鼠各脏器均无明显改变。说明本发明中药制剂内服胶囊剂对大鼠长期用药后毒性小,停药后也没有异样反应,应用安全。
临床资料
患者一般资料
患者均来自本院 2010年—2014年皮肤科患者,共105例。其中男62例,女 43例,均符合真菌性皮肤病诊断标准。随机将患者分成 2组:对照组和治疗组,治疗组55例,对照组50例,入院后采集记录患者一般资料以及病情资料,采用 APACHEⅡ评分标准评估患者病情程度。两组患者资料及 APACHE Ⅱ评分比较均无明显差异( P > 0. 05) 。
诊断标准
可根据病史,临床表现特点诊断。
必要时可进行如下辅助检查:
一、真菌显微镜检查:选取皮损边缘的鳞屑或病发几根。置于玻片上,加入氢氧化钾溶液一滴,加盖玻片。然后放在酒精灯上加热片刻,以促进角质溶解。最后进行镜检观察。真菌检查阳性对诊断有确诊作用,如阴性也不能排除癣的诊断。
二、真菌培养:常规的培养基是采用沙堡弱(sabourauad)培养基。将从病灶取来的鳞屑、毛发或疱膜接种后,放入25~30℃恒温箱中培养。一般5天左右即可见菌落生长,随后可进行菌种鉴定。如经三星期培养无菌落生长,可报告培养阴性。
三、滤过紫外线灯检查:该灯又名伍德(wood)灯,系紫外线通过含有氧化镍的玻璃装置,于暗室里,可见到某些真菌,在滤过紫外线灯照射下产生带色彩的荧光。这样可根据荧光的有无以及色彩不同,在临床上对浅部真菌病,尤其头癣的诊断提供重要参考。此外,本灯对诸如托儿所群体检查也有帮助。
中医辨证标准
参考高等中医院校教科书《中医诊断学》凡属外感热证,多采用脏腑辨证或气血辨证等法则。因此皮肤病的整体辨证,仍应根据其全身证候,分别采用上述法则进行归纳,且以此作为全面分析的主要依据。
同时符合以上真菌性皮肤病诊断标准、中医辨证标准和签署知情同意书者并排除下列因素为纳入本研究病例。
排除标准
(1)慢性心、肝、肺、肾、凝血等器官系统疾病;(2)恶性肿瘤;(3)系统性红斑狼疮;(4) 年龄小于10岁;(5) 孕妇或哺乳期妇女(6);有精神疾病史者(7) 不愿参加试验或不配合治疗者。
治疗方法
对照组:以酮康唑。剂量: 200mg,1次/日。
治疗组:在对照组治疗方案的基础上涂抹本发明实施例中的外用药物,剂量: 200mg,1次/日,疗程共10日。
观察指标
每日观察患者皮肤肤色变化,真菌部位的皮肤变化,及其他症状和体征的变化。
疗效评定标准与结果
疗效评定标准
痊愈:以上所有观察指标全部恢复正常;显效:病情明显好转;有效:病情好转但不明显;无效:病情未见好转或加重,观察指标无明显好转或加重。
结果
两组总体疗效比较,结果见表1。
表1 两组总体疗效比较 [例(%)]
| 组别 | n | 治愈 | 显效 | 有效 | 无效 | 总有效率(%) |
| 治疗组 | 55 | 14(25.5) | 23(41.8) | 12(21.8) | 6(10.9) | 49(89.1) |
| 对照组 | 50 | 8(16.0) | 17(34.0) | 15(30.0) | 10(20.0) | 40(80.0) |
从表1可以看出,采用本发明中药治疗真菌性皮肤病能够提高的总体治疗效果,治疗组与对照组相比,具有可比性。
所有上述的首要实施这一知识产权,并没有设定限制其他形式的实施这种新产品和/或新方法。本领域技术人员将利用这一重要信息,上述内容修改,以实现类似的执行情况。但是,所有修改或改造基于本发明新产品属于保留的权利。
以上所述,仅是本发明的较佳实施例而已,并非是对本发明作其它形式的限制,任何熟悉本专业的技术人员可能利用上述揭示的技术内容加以变更或改型为等同变化的等效实施例。但是凡是未脱离本发明技术方案内容,依据本发明的技术实质对以上实施例所作的任何简单修改、等同变化与改型,仍属于本发明技术方案的保护范围。
Claims (7)
1.用于治疗真菌性皮肤病的中药组合物,其特征在于:所述中药组合物的原料药包括山白菊、鹰不扑、牛至、凹朴皮、牡丹花和冰片、寸节七、八角枫叶、八角香、醉马草、燕窠土、瓣蕊唐松草、鞭打绣球、窿缘桉叶、篱栏子、篦梳剑、没药、千里光、玉兰花、苦参、乳香。
2.如权利要求1所述的用于治疗真菌性皮肤病的中药组合物,其特征在于:是由以下重量份的原料制成:
山白菊40-50份、鹰不扑40-50份、牛至40-50份、凹朴皮40-50份、牡丹花40-50份、冰片40-50份、寸节七30-40份、八角枫叶30-40份、八角香30-40份、醉马草30-40份、燕窠土30-40份、瓣蕊唐松草20-30份、鞭打绣球20-30份、窿缘桉叶20-30份、篱栏子20-30份、篦梳剑20-30份、没药10-20份、千里光10-20份、玉兰花10-20份、苦参10-20份、乳香10-20份。
3.如权利要求1或2所述的用于治疗真菌性皮肤病的中药组合物,其特征在于:是由以下重量份的原料制成:
山白菊42-48份、鹰不扑42-48份、牛至42-48份、凹朴皮42-48份、牡丹花42-48份、冰片42-48份、寸节七32-38份、八角枫叶32-38份、八角香32-38份、醉马草32-38份、燕窠土32-38份、瓣蕊唐松草22-28份、鞭打绣球22-28份、窿缘桉叶22-28份、篱栏子22-28份、篦梳剑22-28份、没药12-18份、千里光12-18份、玉兰花12-18份、苦参12-18份、乳香12-18份。
4.如权利要求1至3所述的用于治疗真菌性皮肤病的中药组合物,其特征在于:是由以下重量份的原料制成:
山白菊45份、鹰不扑45份、牛至45份、凹朴皮45份、牡丹花45份、冰片45份、寸节七35份、八角枫叶35份、八角香35份、醉马草35份、燕窠土35份、瓣蕊唐松草25份、鞭打绣球25份、窿缘桉叶25份、篱栏子25份、篦梳剑25份、没药15份、千里光15份、玉兰花15份、苦参15份、乳香15份。
5.如权利要求1至4所述的用于治疗真菌性皮肤病的中药组合物,其特征在于:所述中药组合物的剂型为膏剂和液体擦洗剂。
6.如权利要求1至5所述的用于治疗真菌性皮肤病的中药组合物的制备方法,其特征在于:所述中药组合物的剂型为中药膏剂时,具体为:
按配方比例取各组分药物加入5-10倍量的60-90%乙醇浸泡1-2小时,热提取2次,每次1-2小时,去上清液,合并提取液, 80-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时 1.36的浸膏,加热浓缩,30分钟~45分钟,提取活性成份,将浓缩液静置成浸膏状,药糊继续加热浓缩至浸膏状,静置后搅拌均匀,再经过冷藏、压平、杀菌封装工艺即成本发明的中药膏剂。
7.如权利要求1至5所述的用于治疗真菌性皮肤病的中药组合物的制备方法,其特征在于:所述中药组合物的剂型为中药擦洗剂时,具体为:
按配方比例将各组分药物分别粉碎,按比例混合,获得混合物,加水至淹没混合物药面3~5cm,浸泡1~2小时,加热煎煮,煮沸后用文火,第一次沸后煎煮2~4小时,滤出药液,滤渣中再次加水至淹没混合物药面3~5cm,加热煮沸,煮沸后用文火,第二次沸后煎煮1~2小时,滤过,合并两次过滤的药液,加入占药液质量0.5%活性炭,保持PH值7.0,加热微沸15分钟,冷却,滤过,袋装,于115℃灭菌30分钟,冷藏48小时,即得本发明的中药擦洗剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510022385.6A CN104474148A (zh) | 2015-01-16 | 2015-01-16 | 用于治疗真菌性皮肤病的中药组合物及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510022385.6A CN104474148A (zh) | 2015-01-16 | 2015-01-16 | 用于治疗真菌性皮肤病的中药组合物及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104474148A true CN104474148A (zh) | 2015-04-01 |
Family
ID=52748849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510022385.6A Pending CN104474148A (zh) | 2015-01-16 | 2015-01-16 | 用于治疗真菌性皮肤病的中药组合物及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104474148A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104940635A (zh) * | 2015-07-16 | 2015-09-30 | 王艳娣 | 一种烫烧伤外用中药组合物 |
| CN105853481A (zh) * | 2016-05-30 | 2016-08-17 | 中国热带农业科学院热带生物技术研究所 | 虎刺楤木提取物或含有虎刺楤木提取物的中药组合物的应用 |
| CN107281328A (zh) * | 2017-06-02 | 2017-10-24 | 王安 | 一种治疗皮肤病的中草药组合物及其制造方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1281155A (zh) * | 1999-06-04 | 2001-01-24 | 权五敬 | 液晶显示器的驱动器 |
| CN1338265A (zh) * | 2000-08-10 | 2002-03-06 | 王磊 | 药物合成的远红外组合物 |
| CN1386536A (zh) * | 2002-05-16 | 2002-12-25 | 高学山 | 一种治疗皮肤疾病的药物 |
| CN102485244A (zh) * | 2010-12-06 | 2012-06-06 | 株洲千金药业股份有限公司 | 一种中药组合物在制备治疗妇科炎症的凝胶剂中的应用 |
-
2015
- 2015-01-16 CN CN201510022385.6A patent/CN104474148A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1281155A (zh) * | 1999-06-04 | 2001-01-24 | 权五敬 | 液晶显示器的驱动器 |
| CN1338265A (zh) * | 2000-08-10 | 2002-03-06 | 王磊 | 药物合成的远红外组合物 |
| CN1386536A (zh) * | 2002-05-16 | 2002-12-25 | 高学山 | 一种治疗皮肤疾病的药物 |
| CN102485244A (zh) * | 2010-12-06 | 2012-06-06 | 株洲千金药业股份有限公司 | 一种中药组合物在制备治疗妇科炎症的凝胶剂中的应用 |
Non-Patent Citations (1)
| Title |
|---|
| 刘巧: "中医皮肤病的治疗", 《继续医学教育》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104940635A (zh) * | 2015-07-16 | 2015-09-30 | 王艳娣 | 一种烫烧伤外用中药组合物 |
| CN105853481A (zh) * | 2016-05-30 | 2016-08-17 | 中国热带农业科学院热带生物技术研究所 | 虎刺楤木提取物或含有虎刺楤木提取物的中药组合物的应用 |
| CN105853481B (zh) * | 2016-05-30 | 2019-11-08 | 中国热带农业科学院热带生物技术研究所 | 虎刺楤木提取物或含有虎刺楤木提取物的中药组合物的应用 |
| CN107281328A (zh) * | 2017-06-02 | 2017-10-24 | 王安 | 一种治疗皮肤病的中草药组合物及其制造方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102091203B (zh) | 一种治疗难愈性创面的外用中药制剂及其制备方法 | |
| CN103721131B (zh) | 一种治疗妇女慢性盆腔炎的中药栓剂及其制备方法 | |
| CN103041173B (zh) | 一种治疗皮炎、湿疹的中药外用制剂及其制备方法 | |
| CN102178804B (zh) | 一种治疗肛周湿疹的中药组合物及其制备方法 | |
| CN104068279A (zh) | 一种鳗鱼配合饲料及其制备方法 | |
| CN103751633A (zh) | 一种治疗下肢静脉曲张的中药组合物及其制备方法 | |
| CN104208245B (zh) | 手足癣中药药浴及制备方法 | |
| CN102579701B (zh) | 复方蒲公英煎剂 | |
| CN102178877B (zh) | 一种治疗阴囊湿疹的外用制剂及其制备方法 | |
| CN109364207A (zh) | 一种治疗和缓解痤疮的组合物及制备方法与应用 | |
| CN104474148A (zh) | 用于治疗真菌性皮肤病的中药组合物及其制备方法 | |
| CN103720841B (zh) | 一种治疗慢性化脓性中耳炎的中药制剂及其制备方法 | |
| CN103735845B (zh) | 一种治疗小儿分泌性中耳炎的中药外用制剂及其制备方法 | |
| CN105662996A (zh) | 治疗月经相关性痤疮的中药面膜 | |
| CN104623376B (zh) | 用于治疗三叉神经痛的药物 | |
| CN104274662A (zh) | 痒必治 | |
| CN103721138B (zh) | 一种治疗酒糟鼻的中药外用制剂及其制备方法 | |
| CN104958633A (zh) | 一种治疗寻常性痤疮的药物及其制备方法 | |
| CN104587043A (zh) | 一种治疗眼部炎症的中药滴眼液及其制备方法 | |
| CN103028040B (zh) | 用于治疗小儿慢性鼻窦炎的中药组合物及其制备方法 | |
| CN114177231A (zh) | 一种退热的药物组合物、退热凝胶及制备方法 | |
| CN104352910A (zh) | 一种治疗妇女带下的中药外用栓剂及其制备方法 | |
| CN104306832A (zh) | 一种治疗邪毒犯心型病毒性心肌炎的中药制剂及其制备方法 | |
| CN103599253B (zh) | 一种用于治疗老年人冬痒症的中药组合物 | |
| CN107929372A (zh) | 治疗甲癣的中药组合物及其制备方法和用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150401 |
|
| RJ01 | Rejection of invention patent application after publication |